tiprankstipranks
Advertisement
Advertisement
Orchestra BioMed gives clinical, regulatory update on BACKBEAT trial timeline
PremiumThe FlyOrchestra BioMed gives clinical, regulatory update on BACKBEAT trial timeline
3M ago
Orchestra BioMed receives $15M payment from Ligand
Premium
The Fly
Orchestra BioMed receives $15M payment from Ligand
3M ago
Orchestra granted additional breakthrough device designation for AVIM therapy
Premium
The Fly
Orchestra granted additional breakthrough device designation for AVIM therapy
3M ago
Orchestra BioMed management to meet with B. Riley
PremiumThe FlyOrchestra BioMed management to meet with B. Riley
5M ago
Orchestra BioMed announces two presentations at THT, CRT 2026 meetings
Premium
The Fly
Orchestra BioMed announces two presentations at THT, CRT 2026 meetings
5M ago
Orchestra BioMed Adopts 2026 Performance-Driven Executive Compensation Plan
Premium
Company Announcements
Orchestra BioMed Adopts 2026 Performance-Driven Executive Compensation Plan
6M ago
Is OBIO a Buy, Before Earnings?
PremiumPre-EarningsIs OBIO a Buy, Before Earnings?
9M ago
Orchestra BioMed Secures FDA Breakthrough Designation
Premium
Company Announcements
Orchestra BioMed Secures FDA Breakthrough Designation
9M ago
Orchestra BioMed price target lowered to $11 from $12 at Barclays
Premium
The Fly
Orchestra BioMed price target lowered to $11 from $12 at Barclays
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100